Physician, Department of Respiratory Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 2006 – Present
Doctor of Medicine in Clinical Internal Medicine, Second Military Medical University, 2004
Administrative Deputy Director of the Respiratory Department, Shanghai Sixth People's Hospital
Yang Danrong , Zhang Yan , Liu Yi *. Correlation Between the Transient Increase of D-Dimer and Thrombolysis at 30d after Anticoagulation Therapy in Patients with Pulmonary Embolism.Clin Appl Thromb Hemost. 2025 Jan-Dec:31:10760296251335250(Q3,IF2.0,一作)
Zhou Y, Yang D, Liu Y.Correlation between anticoagulant initiation time and thrombolysis at 30 days after anticoagulation therapy in patients with pulmonary embolism.Front Med (Lausanne). 2025 Nov 18;12:1690899(Q1 IF3.0 共一)
Yi Liu, Danrong Yang*.Correlation between decreased PaCO2 and thrombus site and 90d prognosis in patients with acute pulmonary embolism. Front Med (Lausanne). 2025 Jun 17:12:1601169(Q1 IF3.0 通讯)
Yi Liu, Danrong Yang*.Does pulmonary embolism guideline increase pulmonary vascular obstruction index and help to reducing the misunderstanding severity of pulmonary embolism? Journal of Thoracic Disease. 2024;16(5):3361-3365.IF:3.0
Yi Lu, Zeyu Liu, Yunjiao Zhang, Xiuhua Wu, Wei Bian, Shan Shan, Danrong Yang and Tao Ren.METTL3-mediated m6A RNA methylation Checkfor updates induces the differentiation oflung resident mesenchymal stem cells into myofibroblasts via the miR-21/PTEN pathway.Respiratory Research.2023;24:300
Lu, Yi; Zhang, Tiefeng; Shan, Shan; Wang, Shenqi; Bian, Wei; Ren, Tao; Yang Danrong *; MiR-124 regulates transforming growth factor-beta 1 induced differentiation of lung resident mesenchymal stem cells to myofibroblast by repressing Wnt/beta-catenin signaling, Developmental Biology, 2019, 449(2): 115-121
01/07/ 2025 – 01/07/2027
Project of the Medical and Health Science and Technology Development Research Center, National Health Commission of the People's Republic of China
Project No.: WKZX2024HK0110
Title: A Real-World Study on Standardized Respiratory Rehabilitation for Patients with Chronic Obstructive Pulmonary Disease
Duration: Funding: RMB 150,000
Role: Principal Investigator
01/01/2018-01/01/2022
Pharmaceutical Clinical Trial
Title: A 52-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of GSK3511294 as Adjunctive Therapy in Adult and Adolescent Subjects with Severe Uncontrolled Asthma of Eosinophilic Phenotype
Role: Principal Investigator